Bewersdorf JP, Shimony S, Shallis RM, Liu Y, et al. Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. Am J Hematol 2024 May 15. doi: 10.1002/ajh.27366.
PMID: 38751104